4baseCare Raises ₹38Cr Series B
4baseCare, a Bengaluru-based healthtech startup that uses genomics and AI to provide personalized oncology care, has raised ₹38Cr in funding, completing its Series B round at a total valuation of ₹128Cr.
This round was led by growX Ventures, with participation from several existing investors.
The company plans to use the capital to expand its genomics laboratory network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. Additionally, the funds will support the scaling of its AI-driven precision oncology platform, OncoTwin.
Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare leverages advanced genomics, bioinformatics, and AI to develop personalized cancer care solutions. The company provides clinicians with data-driven, actionable insights to improve patient outcomes.
Funding Details
Company: 4baseCare
Raised: ₹38Cr
Round: Series B
Funding Date: June 11, 2026
Lead Investor: growX Ventures
Additional Investors: Undisclosed existing investors
Software Category: Healthtech
Company Website: https://4basecare.com